PharmaJet Vaccine Delivery Featured at Sabin Vaccine Institute Conference
Retrieved on:
Tuesday, March 1, 2022
Science, Other Science, Biotechnology, Pharmaceutical, Medical Supplies, Health, Medical Devices, Infectious Diseases, WHO, Social media, U.S. FDA, Vaccine, Research, Policy, Immunization, World, Sabin Vaccine Institute, CE marking, Gonzaga University, Twitter, Ecosystem, LinkedIn, Aircraft, Vaccination, Vaccine hesitancy, Certification, Solution, Polio, Use, System, COVID-19, Needle, CEO, Sabin, Caregiver, Injection, Child, Technology, Review, Partnership, Poster, World Health Organization, PQS, PharmaJet, the Sabin Vaccine Institute, the Vaccine Acceptance and Demand Initiative (VARN), PHARMAJET, THE SABIN VACCINE INSTITUTE, THE VACCINE ACCEPTANCE AND DEMAND INITIATIVE (VARN)
The poster, entitled Needle-free delivery of vaccines bridges vaccine coverage gaps in Somalia and Pakistan, is authored by J.V.
Key Points:
- The poster, entitled Needle-free delivery of vaccines bridges vaccine coverage gaps in Somalia and Pakistan, is authored by J.V.
- Recent WHO-sponsored introductions of needle-free intradermal delivery of inactivated polio vaccine (ID-IPV) in Pakistan and Somalia have resulted in the immunization of over 3 million children.
- The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.
- The Sabin Vaccine Institutes Vaccine Acceptance and Demand program is actively building a multidisciplinary, global network referred to as the Vaccination Acceptance Research Network (VARN).